ijms-logo

Journal Browser

Journal Browser

The Role of Phytochemicals in Neurological Disorders

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Bioactives and Nutraceuticals".

Deadline for manuscript submissions: closed (20 April 2024) | Viewed by 1144

Special Issue Editors


E-Mail Website
Guest Editor

E-Mail Website
Guest Editor
Laboratory of Food and Health, Food and Technology Department, National Council for Scientific Research (CEBAS-CSIC), Murcia, Spain
Interests: food and health; bioactive compounds; polyphenols; cell culture and animal models; clinical trials; cardiovascular; cancer; inflammation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Phytochemicals present in foods, spices and herbs, such as polyphenols, carotenoids and phytosterols, among others, constitute an unlimited source of molecules available for the prevention of numerous diseases and improving human health. Thousands of studies have already firmly established the intimate association between phytochemicals and their significantly neuroprotective activity in neurological disorders (i.e., dementia, cognitive decline, Alzheimer’s, Parkinson’s, stroke, ischemic injury, cancers, etc.), most of which are associated with gradual loss of neurons attributed to increased oxidative stress at the cellular level.

In recent years, bioactive phytochemicals have attracted enormous interest for their roles in preventive strategies (increasing the daily intake) and as adjuvants in the treatment of these pathologies (administered in co-treatment or present in pharmaceutical forms) owing to their potent antioxidant and anti-inflammatory activities. Food supplements containing phytochemicals are now widely used, and it seems that this market will tend to grow more and more in the coming years.

Led by Dr. Alessandro Attanzio, Dr. Antonio Cilla, Dr. Antonio González-Sarrías and our Topical Advisory Panel Member Dr. Ignazio Restivo (University of Palermo). For this Special Issue “The Role of Phytochemicals in Neurological Disorders”, we invite investigators to contribute with original research articles as well as review articles covering the biological effect of natural products in the prevention of neurodegeneration through comparisons between both relevant in vivo and in vitro models and with particular focus on biochemical signaling pathways.

Dr. Alessandro Attanzio
Dr. Antonio Cilla
Dr. Antonio González-Sarrías
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • phytochemicals
  • neurodegeneration
  • antioxidant activity
  • anti-inflammatory activity
  • nutrition
  • bioactive
  • inhibitor
  • functional foods
  • nutraceuticals
  • molecular mechanism

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

23 pages, 3436 KiB  
Article
Geniposide and Harpagoside Functionalized Cerium Oxide Nanoparticles as a Potential Neuroprotective
by Rosa Martha Pérez Gutiérrez, Luis Miguel Rodríguez-Serrano, José Fidel Laguna-Chimal, Mónica de la Luz Corea, Silvia Patricia Paredes Carrera and Julio Téllez Gomez
Int. J. Mol. Sci. 2024, 25(8), 4262; https://doi.org/10.3390/ijms25084262 - 11 Apr 2024
Viewed by 486
Abstract
Alzheimer’s disease is associated with protein aggregation, oxidative stress, and the role of acetylcholinesterase in the pathology of the disease. Previous investigations have demonstrated that geniposide and harpagoside protect the brain neurons, and cerium nanoparticles (CeO2 NPs) have potent redox and antioxidant [...] Read more.
Alzheimer’s disease is associated with protein aggregation, oxidative stress, and the role of acetylcholinesterase in the pathology of the disease. Previous investigations have demonstrated that geniposide and harpagoside protect the brain neurons, and cerium nanoparticles (CeO2 NPs) have potent redox and antioxidant properties. Thus, the effect of nanoparticles of Ce NPs and geniposide and harpagoside (GH/CeO2 NPs) on ameliorating AD pathogenesis was established on AlCl3-induced AD in mice and an aggregation proteins test in vitro. Findings of spectroscopy analysis have revealed that GH/CeO2 NPs are highly stable, nano-size, spherical in shape, amorphous nature, and a total encapsulation of GH in cerium. Treatments with CeO2 NPs, GH/CeO2 NPs, and donepezil used as positive control inhibit fibril formation and protein aggregation, protect structural modifications in the BSA-ribose system, have the ability to counteract Tau protein aggregation and amyloid-β1–42 aggregation under fibrillation condition, and are able to inhibit AChE and BuChE. While the GH/CeO2 NPs, treatment in AD induced by AlCl3 inhibited amyloid-β1–42, substantially enhanced the memory, the cognition coordination of movement in part AD pathogenesis may be alleviated through reducing amyloidogenic pathway and AChE and BuChE activities. The findings of this work provide important comprehension of the chemoprotective activities of iridoids combined with nanoparticles. This could be useful in the development of new therapeutic methods for the treatment of neurodegenerative diseases. Full article
(This article belongs to the Special Issue The Role of Phytochemicals in Neurological Disorders)
Show Figures

Figure 1

Back to TopTop